1456693-55-2 Usage
Uses
Used in Pharmaceutical Applications:
(R)-methyl 1-isopropyl-7-(methylsulfonyl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyrazine-8-carboxylate is used as a potential pharmaceutical agent for targeting specific biological pathways due to its unique structure and functional groups.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (R)-methyl 1-isopropyl-7-(methylsulfonyl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyrazine-8-carboxylate is used as a compound of interest for studying its interactions with biological targets and its potential applications in drug discovery and development.
Used in Drug Synthesis:
(R)-methyl 1-isopropyl-7-(methylsulfonyl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyrazine-8-carboxylate is used as a key intermediate in the synthesis of novel drugs, potentially leading to the development of new therapeutic agents.
Used in Chemical Synthesis Research:
In the realm of chemical synthesis, (R)-methyl 1-isopropyl-7-(methylsulfonyl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyrazine-8-carboxylate is used as a subject of study to understand its reactivity, synthesis methods, and potential applications in creating new compounds with desired properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1456693-55-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,5,6,6,9 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1456693-55:
(9*1)+(8*4)+(7*5)+(6*6)+(5*6)+(4*9)+(3*3)+(2*5)+(1*5)=202
202 % 10 = 2
So 1456693-55-2 is a valid CAS Registry Number.
1456693-55-2Relevant articles and documents
COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS
-
Paragraph 00241, (2016/05/19)
Provided herein are compounds and pharmaceutically acceptable salts thereof that are useful therapeutics for acute coronary syndrome and related disorders.
LIVER X RECEPTOR MODULATORS
-
Page/Page column 43, (2013/09/26)
Provided herein are novel compounds and pharmaceutically acceptable salts thereof that are liver X receptor modulators. Also provided are compositions comprising compounds of the invention and a carrier. Additionally, use of the compounds herein and methods for treating a disease or disorder associated with the liver X receptor are further described.